Public Cloud Service
Public Cloud Service market is segmented by players, region (country), by Type and by Application ... Read More
Global Psoriasis Therapeutics Market Insights and Forecast to 2028
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriasis Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Therapeutics Market Perspective (2017-2028)
2.2 Psoriasis Therapeutics Growth Trends by Region
2.2.1 Psoriasis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Psoriasis Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Psoriasis Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Psoriasis Therapeutics Market Dynamics
2.3.1 Psoriasis Therapeutics Industry Trends
2.3.2 Psoriasis Therapeutics Market Drivers
2.3.3 Psoriasis Therapeutics Market Challenges
2.3.4 Psoriasis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Therapeutics Players by Revenue
3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriasis Therapeutics Revenue
3.4 Global Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2021
3.5 Psoriasis Therapeutics Key Players Head office and Area Served
3.6 Key Players Psoriasis Therapeutics Product Solution and Service
3.7 Date of Enter into Psoriasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2023-2028)
5 Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Psoriasis Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Psoriasis Therapeutics Market Size (2017-2028)
6.2 North America Psoriasis Therapeutics Market Size by Type
6.2.1 North America Psoriasis Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Psoriasis Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Psoriasis Therapeutics Market Share by Type (2017-2028)
6.3 North America Psoriasis Therapeutics Market Size by Application
6.3.1 North America Psoriasis Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Psoriasis Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Psoriasis Therapeutics Market Share by Application (2017-2028)
6.4 North America Psoriasis Therapeutics Market Size by Country
6.4.1 North America Psoriasis Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Psoriasis Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Psoriasis Therapeutics Market Size (2017-2028)
7.2 Europe Psoriasis Therapeutics Market Size by Type
7.2.1 Europe Psoriasis Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Psoriasis Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Psoriasis Therapeutics Market Share by Type (2017-2028)
7.3 Europe Psoriasis Therapeutics Market Size by Application
7.3.1 Europe Psoriasis Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Psoriasis Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Psoriasis Therapeutics Market Share by Application (2017-2028)
7.4 Europe Psoriasis Therapeutics Market Size by Country
7.4.1 Europe Psoriasis Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Psoriasis Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Psoriasis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Psoriasis Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Psoriasis Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Psoriasis Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Psoriasis Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Psoriasis Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Psoriasis Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Psoriasis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Psoriasis Therapeutics Market Size (2017-2028)
9.2 Latin America Psoriasis Therapeutics Market Size by Type
9.2.1 Latin America Psoriasis Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Psoriasis Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Psoriasis Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Psoriasis Therapeutics Market Size by Application
9.3.1 Latin America Psoriasis Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Psoriasis Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Psoriasis Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Psoriasis Therapeutics Market Size by Country
9.4.1 Latin America Psoriasis Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Psoriasis Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Psoriasis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Psoriasis Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Psoriasis Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Psoriasis Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Psoriasis Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Psoriasis Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Psoriasis Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Psoriasis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Details
11.1.2 Astellas Pharma Inc. Business Overview
11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
11.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2017-2022)
11.1.5 Astellas Pharma Inc. Recent Developments
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
11.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2017-2022)
11.2.5 AstraZeneca plc Recent Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2017-2022)
11.3.5 Boehringer Ingelheim GmbH Recent Developments
11.4 F. Hofffmann-La Roche
11.4.1 F. Hofffmann-La Roche Company Details
11.4.2 F. Hofffmann-La Roche Business Overview
11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
11.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2017-2022)
11.4.5 F. Hofffmann-La Roche Recent Developments
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Details
11.5.2 GlaxoSmithKline plc Business Overview
11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
11.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2017-2022)
11.5.5 GlaxoSmithKline plc Recent Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
11.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2017-2022)
11.6.5 Merck & Co., Inc. Recent Developments
11.7 Valeant Pharmaceuticals International, Inc.
11.7.1 Valeant Pharmaceuticals International, Inc. Company Details
11.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
11.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2017-2022)
11.7.5 Valeant Pharmaceuticals International, Inc. Recent Developments
11.8 Biocon Limited
11.8.1 Biocon Limited Company Details
11.8.2 Biocon Limited Business Overview
11.8.3 Biocon Limited Psoriasis Therapeutics Introduction
11.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2017-2022)
11.8.5 Biocon Limited Recent Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2017-2022)
11.9.5 Eli Lilly and Company Recent Developments
11.10 G & W Laboratories Inc.
11.10.1 G & W Laboratories Inc. Company Details
11.10.2 G & W Laboratories Inc. Business Overview
11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
11.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2017-2022)
11.10.5 G & W Laboratories Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of PDE4 Inhibitors
Table 4. Key Players of Interleukin Blockers
Table 5. Key Players of Others
Table 6. Global Psoriasis Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Psoriasis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Psoriasis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Psoriasis Therapeutics Market Share by Region (2017-2022)
Table 10. Global Psoriasis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Psoriasis Therapeutics Market Share by Region (2023-2028)
Table 12. Psoriasis Therapeutics Market Trends
Table 13. Psoriasis Therapeutics Market Drivers
Table 14. Psoriasis Therapeutics Market Challenges
Table 15. Psoriasis Therapeutics Market Restraints
Table 16. Global Psoriasis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Psoriasis Therapeutics Revenue Share by Players (2017-2022)
Table 18. Global Top Psoriasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2021)
Table 19. Ranking of Global Top Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Psoriasis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psoriasis Therapeutics Product Solution and Service
Table 23. Date of Enter into Psoriasis Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriasis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Psoriasis Therapeutics Revenue Market Share by Type (2017-2022)
Table 27. Global Psoriasis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Psoriasis Therapeutics Revenue Market Share by Type (2023-2028)
Table 29. Global Psoriasis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Psoriasis Therapeutics Revenue Share by Application (2017-2022)
Table 31. Global Psoriasis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Psoriasis Therapeutics Revenue Share by Application (2023-2028)
Table 33. North America Psoriasis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Psoriasis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Psoriasis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Psoriasis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Psoriasis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Psoriasis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Psoriasis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Psoriasis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Psoriasis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Psoriasis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Psoriasis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Psoriasis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Psoriasis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Psoriasis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Psoriasis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Psoriasis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Psoriasis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Psoriasis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Psoriasis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Psoriasis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Psoriasis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Psoriasis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Psoriasis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Psoriasis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Psoriasis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Psoriasis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Psoriasis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Psoriasis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Psoriasis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Psoriasis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 63. Astellas Pharma Inc. Company Details
Table 64. Astellas Pharma Inc. Business Overview
Table 65. Astellas Pharma Inc. Psoriasis Therapeutics Product
Table 66. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 67. Astellas Pharma Inc. Recent Developments
Table 68. AstraZeneca plc Company Details
Table 69. AstraZeneca plc Business Overview
Table 70. AstraZeneca plc Psoriasis Therapeutics Product
Table 71. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 72. AstraZeneca plc Recent Developments
Table 73. Boehringer Ingelheim GmbH Company Details
Table 74. Boehringer Ingelheim GmbH Business Overview
Table 75. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product
Table 76. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 77. Boehringer Ingelheim GmbH Recent Developments
Table 78. F. Hofffmann-La Roche Company Details
Table 79. F. Hofffmann-La Roche Business Overview
Table 80. F. Hofffmann-La Roche Psoriasis Therapeutics Product
Table 81. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 82. F. Hofffmann-La Roche Recent Developments
Table 83. GlaxoSmithKline plc Company Details
Table 84. GlaxoSmithKline plc Business Overview
Table 85. GlaxoSmithKline plc Psoriasis Therapeutics Product
Table 86. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 87. GlaxoSmithKline plc Recent Developments
Table 88. Merck & Co., Inc. Company Details
Table 89. Merck & Co., Inc. Business Overview
Table 90. Merck & Co., Inc. Psoriasis Therapeutics Product
Table 91. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 92. Merck & Co., Inc. Recent Developments
Table 93. Valeant Pharmaceuticals International, Inc. Company Details
Table 94. Valeant Pharmaceuticals International, Inc. Business Overview
Table 95. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product
Table 96. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 97. Valeant Pharmaceuticals International, Inc. Recent Developments
Table 98. Biocon Limited Company Details
Table 99. Biocon Limited Business Overview
Table 100. Biocon Limited Psoriasis Therapeutics Product
Table 101. Biocon Limited Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 102. Biocon Limited Recent Developments
Table 103. Eli Lilly and Company Company Details
Table 104. Eli Lilly and Company Business Overview
Table 105. Eli Lilly and Company Psoriasis Therapeutics Product
Table 106. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 107. Eli Lilly and Company Recent Developments
Table 108. G & W Laboratories Inc. Company Details
Table 109. G & W Laboratories Inc. Business Overview
Table 110. G & W Laboratories Inc. Psoriasis Therapeutics Product
Table 111. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 112. G & W Laboratories Inc. Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriasis Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. TNF Inhibitors Features
Figure 3. PDE4 Inhibitors Features
Figure 4. Interleukin Blockers Features
Figure 5. Others Features
Figure 6. Global Psoriasis Therapeutics Market Share by Application: 2021 VS 2028
Figure 7. Oral Case Studies
Figure 8. Parenteral Case Studies
Figure 9. Topical Case Studies
Figure 10. Psoriasis Therapeutics Report Years Considered
Figure 11. Global Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Psoriasis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Psoriasis Therapeutics Market Share by Region: 2021 VS 2028
Figure 14. Global Psoriasis Therapeutics Market Share by Players in 2021
Figure 15. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2021
Figure 17. North America Psoriasis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Psoriasis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 19. North America Psoriasis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 20. North America Psoriasis Therapeutics Market Size Share by Country (2017-2028)
Figure 21. United States Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Psoriasis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Psoriasis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 25. Europe Psoriasis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 26. Europe Psoriasis Therapeutics Market Size Share by Country (2017-2028)
Figure 27. Germany Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Psoriasis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Psoriasis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Psoriasis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Psoriasis Therapeutics Market Size Share by Region (2017-2028)
Figure 37. China Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Psoriasis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Psoriasis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Psoriasis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Psoriasis Therapeutics Market Size Share by Country (2017-2028)
Figure 47. Mexico Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Psoriasis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Psoriasis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Psoriasis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Psoriasis Therapeutics Market Size Share by Country (2017-2028)
Figure 53. Turkey Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 57. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 58. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 59. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 60. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 61. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 62. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 63. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 65. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Astellas Pharma Inc. AstraZeneca plc Boehringer Ingelheim GmbH F. Hofffmann-La Roche GlaxoSmithKline plc Merck & Co., Inc. Valeant Pharmaceuticals International, Inc. Biocon Limited Eli Lilly and Company G & W Laboratories Inc.